Marijuana Rescheduling and Trump Cannabis Legalization

Few policy debates capture as much national attention as marijuana rescheduling. For decades, cannabis has been classified as a Schedule I drug, alongside heroin and LSD, officially deemed to have “no medical use.”

But growing medical evidence, state-level legalization, and overwhelming public support have made weed rescheduling one of the most pressing issues in U.S. drug policy.

At the same time, Trump and cannabis policy have emerged as key political talking points. Ever since the 2024 election cycle and 2025 DEA review, questions like “will Trump legalize cannabis?” and “how would Trump handle marijuana rescheduling?” are dominating cannabis news.

This article explores the marijuana rescheduling timeline, DEA and federal updates, Trump on cannabis, and what full federal marijuana legalization would mean for America.

What Does Marijuana Rescheduling Mean?

Weed rescheduling refers to moving cannabis from Schedule I to a lower classification (II–V) under the Controlled Substances Act.

• Schedule I: No accepted medical use, high abuse risk (current classification).
• Schedule II: Cocaine, fentanyl, opioids — accepted medical use but tightly controlled.
• Schedule III: Anabolic steroids, ketamine — medical use, moderate abuse potential.
• Schedule IV & V: Benzodiazepines, cough medicines — wide medical use, low abuse potential.

Key Takeaway:

• Marijuana rescheduling would acknowledge cannabis has medical value.
• It would not equal federal legalization, but it would:
  • Expand research.
  • Change tax laws (eliminating IRS Code 280E).
  • Lower criminal penalties.

Marijuana Rescheduling Timeline

1970s–2000s: Petitions and Rejections

Advocates and doctors petitioned the DEA to reschedule marijuana as early as 1972. All efforts were denied for decades.

2016: DEA Denial

The DEA reaffirmed cannabis as Schedule I, despite public health data.

Marijuana Rescheduling 2024

In 2023, the Department of Health and Human Services (HHS) recommended moving cannabis to Schedule III.

In 2024, rescheduling news dominated headlines, as the DEA confirmed it was formally reviewing the recommendation.

Marijuana Rescheduling 2025

The DEA marijuana rescheduling decision is expected in late 2025 or possibly 2026. This could be the most significant shift in federal drug law in half a century. But will Trump legalize pot? Doubtful!

Federal Cannabis Rescheduling vs. Legalization

It’s essential to distinguish weed rescheduling from federal marijuana legalization.

• Rescheduling: Acknowledges medical use, loosens restrictions, but keeps marijuana federally controlled.
• Legalization: Removes marijuana from the Controlled Substances Act entirely, allowing interstate commerce and treating cannabis like alcohol.

Trump cannabis policy and future political decisions will determine whether America stops at marijuana rescheduling or moves to full legalization.

Trump and Cannabis: Policy and Legalization

Trump on Cannabis

Donald Trump has historically taken a mixed stance:

• As president, Trump expressed support for states’ rights on cannabis.
• He signed the 2018 Farm Bill, legalizing hemp and CBD nationwide.
• He also appointed officials like Jeff Sessions, who attempted to reinstate federal crackdowns on marijuana.

Trump and Cannabis Legalization

Trump never supported full federal marijuana legalization, but he indicated openness to medical use.

Recently, in campaign discussions, Trump and cannabis legalization has resurfaced, with speculation about whether he would back federal reform if reelected.

Trump Cannabis Policy 2025

• He could support federal marijuana rescheduling as a compromise move.
• Advocates wonder: Will Trump legalize cannabis? While full legalization is uncertain, Trump could influence the DEA marijuana rescheduling timeline or support incremental reform. So far he has mentioned marijuana rescheduling but nothing has come from it.

Trump’s Current Stance on Cannabis Rescheduling

Much of the debate around Donald Trump’s cannabis position has relied on his past actions and ambiguous statements.

While he has not issued a detailed plan for federal cannabis reform, Trump has recently signaled skepticism about broad legalization but has remained relatively quiet on the DEA’s current review of the rescheduling recommendation.

So far, his public comments suggest:

• Support for states’ rights, meaning states can continue to decide on legalization.
• Caution about recreational cannabis expansion but less opposition toward medical cannabis.
• Uncertainty on rescheduling, with no formal endorsement or opposition to the DEA’s recommendation to move cannabis from Schedule I to Schedule III.

Without explicit policy commitments, Trump’s stance remains fluid and influenced by the political climate, his voter base, and congressional action.

The Role of Congress in Cannabis Reform

While executive agencies like the DEA and HHS hold significant influence, Congress ultimately has the power to reshape federal cannabis law. Current congressional activity includes:

• Legislative Proposals: Bills like the SAFE Banking Act (to allow cannabis businesses access to financial services) and the MORE Act (which proposes full descheduling and legalization).
• Key Congressional Leaders: Some Democrats, such as Senate Majority Leader Chuck Schumer, continue to push for comprehensive reform, while Republicans remain divided. Certain GOP lawmakers, particularly from states with legal markets, have expressed openness to banking and incremental reforms.
• Election Impact: A change in the White House or a shift in congressional control could accelerate or stall cannabis policy. Unified government action would make legalization or rescheduling more likely, while divided government may maintain the status quo.

Economic Impact of Rescheduling

The potential rescheduling of cannabis from Schedule I to Schedule III would have major economic implications for the industry.

• Tax Burden Relief: Currently, cannabis businesses face a punitive tax structure under Section 280E of the IRS code, which prevents them from deducting ordinary business expenses. Rescheduling would effectively repeal 280E’s restrictions, allowing companies to operate on a level playing field with other industries.
• Capital Markets: Rescheduling could encourage banks, credit unions, and institutional investors to engage more openly with cannabis companies, improving access to loans and equity investment.
• Interstate Commerce: While rescheduling alone would not legalize interstate commerce, it could create momentum for eventual regulatory frameworks to allow cross-state distribution, which would reshape supply chains and pricing.
• Job Creation & Revenue: Broader acceptance of cannabis at the federal level is expected to boost job growth, state tax revenues, and new business development across cultivation, retail, and ancillary services.

Public Opinion and Advocacy

Public opinion has shifted dramatically in favor of cannabis reform, making it a central factor in the rescheduling debate.

• Public Support: Recent polling shows that nearly 70% of Americans support full legalization, while over 90% support medical cannabis. This bipartisan consensus is stronger than at any point in history.
• Advocacy Groups: Organizations like NORML, the Marijuana Policy Project (MPP), and the Drug Policy Alliance have played key roles in educating lawmakers and the public about the benefits of reform. Industry groups, such as the National Cannabis Roundtable, have amplified the push for rescheduling by emphasizing tax relief and job creation.
• Social Justice Advocacy: Many groups continue to argue that rescheduling should go hand-in-hand with expungement of cannabis convictions, ensuring that communities most affected by prohibition benefit from reform.

What Would Happen if Marijuana Was Legalized Federally?

If federal marijuana legalization occurred, whether under Trump, Biden, or a future administration, the implications would be massive:

1. Economic Impacts

• Billions in tax revenue from federal cannabis regulation.
• Growth in jobs and cannabis industry expansion.
• Lower costs for businesses by ending tax penalties like 280E.

2. Criminal Justice Reform

• Expungement of federal cannabis convictions.
• Massive reductions in marijuana-related incarcerations.
• Alignment between federal and state laws, reducing legal confusion.

3. Public Health and Research

• Full-scale clinical trials on medical cannabis for conditions like PTSD, epilepsy, and chronic pain.
• FDA-approved cannabis medicines.

4. Business and Interstate Commerce

• Interstate cannabis sales across state lines.
• National marijuana brands similar to alcohol and tobacco giants.
• Major corporations entering cannabis markets.

Marijuana Rescheduling News and Updates

• DEA marijuana rescheduling 2025: All eyes are on the DEA.
• Marijuana rescheduling update: HHS recommended Schedule III, DEA pending.
• Marijuana rescheduling date: Still unknown, but likely before the 2025 election cycle concludes.

Trump cannabis legalization positions and Trump cannabis policy updates will likely influence this timeline, especially if marijuana rescheduling becomes a 2026 election issue.

Political Context: Trump, Biden, and Beyond

• Biden Administration: Initiated HHS review, signaling support for rescheduling.
• Trump and Cannabis: Mixed record, but possible 2025 influence on weed rescheduling.
• Congressional Republicans & Democrats: Some GOP lawmakers now back rescheduling; Democrats often push for full legalization.

Marijuana Rescheduling FAQs

Conclusion on Marijuana Rescheduling & Legalization

The marijuana rescheduling debate is at its most critical point in decades. With the DEA marijuana rescheduling timeline nearing its 2025 conclusion and both Trump cannabis policy and Biden’s cannabis reforms shaping political momentum, the next year may redefine cannabis in America.

Whether it’s weed rescheduling to Schedule III or eventual federal marijuana legalization, the outcome will impact the economy, justice system, healthcare, and millions of Americans who rely on cannabis for wellness.

As voters weigh Trump and cannabis legalization positions, one thing is clear: the question is no longer if marijuana policy will change , but when.